(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(-0.06%) $82.58
(1.53%) $2.06
(-0.69%) $2 341.50
(-1.50%) $27.25
(-0.29%) $958.70
(0.20%) $0.934
(0.34%) $11.02
(0.15%) $0.797
(0.01%) $93.31
Quarter results tomorrow
(bmo 2024-05-01)
Expected move: +/- 3.19%
@ $13.52
Utstedt: 13 feb 2024 @ 21:46
Avkastning: 4.81%
Forrige signal: feb 13 - 19:38
Forrige signal:
Avkastning: 0.19 %
Live Chart Being Loaded With Signals
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture...
Stats | |
---|---|
Dagens volum | 1.56M |
Gjennomsnittsvolum | 2.10M |
Markedsverdi | 3.28B |
EPS | $0 ( 2024-02-27 ) |
Neste inntjeningsdato | ( $0.340 ) 2024-05-01 |
Last Dividend | $0.300 ( 2023-11-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 236.17 |
ATR14 | $0.00800 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-29 | Porter Clifton J Ii | Buy | 754 | Common Stock |
2024-02-29 | Malehorn Jeffrey A. | Buy | 1 040 | Common Stock |
2024-02-29 | Kono Ann | Buy | 741 | Common Stock |
2024-02-29 | Katzmann Lynne S | Buy | 1 108 | Common Stock |
2024-02-29 | Foster Michael J | Buy | 1 040 | Common Stock |
INSIDER POWER |
---|
57.36 |
Last 100 transactions |
Buy: 1 132 168 | Sell: 305 519 |
Volum Korrelasjon
Sabra Health Care REIT Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Sabra Health Care REIT Korrelasjon - Valuta/Råvare
Sabra Health Care REIT Økonomi
Annual | 2023 |
Omsetning: | $655.85M |
Bruttogevinst: | $277.51M (42.31 %) |
EPS: | $0.0595 |
FY | 2023 |
Omsetning: | $655.85M |
Bruttogevinst: | $277.51M (42.31 %) |
EPS: | $0.0595 |
FY | 2022 |
Omsetning: | $624.81M |
Bruttogevinst: | $462.20M (73.97 %) |
EPS: | $-0.340 |
FY | 2021 |
Omsetning: | $569.55M |
Bruttogevinst: | $428.34M (75.21 %) |
EPS: | $-0.520 |
Financial Reports:
No articles found.
Sabra Health Care REIT Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.300 (N/A) |
$0.300 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $3.91 | 2010-11-16 |
Last Dividend | $0.300 | 2023-11-16 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-30 | |
Next Payout Date | N/A | |
# dividends | 52 | -- |
Total Paid Out | $22.61 | -- |
Avg. Dividend % Per Year | 5.65% | -- |
Score | 6.27 | -- |
Div. Sustainability Score | 7.35 | |
Div.Growth Potential Score | 5.92 | |
Div. Directional Score | 6.63 | -- |
Year | Amount | Yield |
---|---|---|
2010 | $3.91 | 14.00% |
2011 | $0.960 | 5.07% |
2012 | $1.320 | 10.80% |
2013 | $1.360 | 6.06% |
2014 | $1.510 | 5.83% |
2015 | $1.600 | 5.19% |
2016 | $1.670 | 8.27% |
2017 | $1.730 | 7.03% |
2018 | $1.800 | 9.43% |
2019 | $1.800 | 11.20% |
2020 | $1.350 | 6.44% |
2021 | $1.200 | 7.13% |
2022 | $1.200 | 8.68% |
2023 | $1.200 | 9.52% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0212 | 1.500 | 9.58 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00255 | 1.200 | 9.91 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.00475 | 1.500 | -1.058 | -1.588 | [0.1 - 1] |
payoutRatioTTM | 20.17 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 2.35 | 0.800 | 3.26 | 2.61 | [1 - 3] |
quickRatioTTM | 2.35 | 0.800 | 0.895 | 0.716 | [0.8 - 2.5] |
cashRatioTTM | 0.202 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.448 | -1.500 | 2.53 | -3.79 | [0 - 0.6] |
interestCoverageTTM | 2.54 | 1.000 | -0.171 | -0.171 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.300 | 2.00 | 9.57 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.882 | 2.00 | 9.56 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.861 | -1.500 | 6.55 | -9.83 | [0 - 2.5] |
grossProfitMarginTTM | 0.633 | 1.000 | 2.79 | 2.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.503 | 1.000 | 1.935 | 1.935 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.125 | 1.000 | -0.419 | -0.419 | [0.2 - 2] |
assetTurnoverTTM | 0.120 | 0.800 | -2.53 | -2.02 | [0.5 - 2] |
Total Score | 7.35 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 234.32 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.00475 | 2.50 | -0.680 | -1.588 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.882 | 2.00 | 9.71 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 8.61 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.300 | 2.00 | 9.57 | 10.00 | [0 - 30] |
payoutRatioTTM | 20.17 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 5.78 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.463 | 1.000 | 0.913 | 0 | [0.1 - 0.5] |
Total Score | 5.92 |
Sabra Health Care REIT
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.